April 10, 2018

TGaS Inaugurates the "BoBs" Awards for Best of Benchmark

E.Norriton, Penn. April 10, 2018. Seven companies achieved the highest honors in TGaS® Advisors' inaugural annual search for the biopharmaceutical industry's Best of Benchmark, or "BoBs," awarded in 15 categories. The BoBs, for excellence in commercial operations, are based on the firm's benchmarking of both leading and emerging life sciences companies. The BoBs will be presented at a special awards ceremony on April 30, 2018, in Princeton, NJ.

"The BoBs Awards recognize outstanding achievement and acknowledge the unsung heroes in pharma who work every day to support sales, marketing and market access," said Steve Gerard, TGaS Founder and Board Chairman.

Inaugural award winners and categories:

Commercial Sectors

Contract Management: Novartis

End to End (E2E) Promotional Content Lifecycle: Gilead Sciences, Inc.

Field Operations Management: Genentech, a member of the Roche Group

Forecasting in Commercial Analytics & Insights: Genentech, a member of the Roche Group

Incentive Compensation Communication in the Emerging Life Sciences Network (elsN): Taiho Oncology, Inc.

Incentive Compensation Excellence: Sunovion Pharmaceuticals

Leadership Development: Gilead Sciences, Inc.

Roster Management within Enterprise Data Management: Bayer

Digital & Multichannel Marketing

Consumer Digital Display Efficiency: Sunovion Pharmaceuticals for Aptiom®

Consumer Mobile Site Speed: Sunovion Pharmaceuticals for UtibronTM

Consumer Mobile Website Volume: Bristol-Myers Squibb for Orencia®

Consumer Paid Search Efficiency: Sunovion Pharmaceuticals for Aptiom®

Consumer Website Volume: Eli Lilly & Company for Cialis®

HCP Website Volume: Eli Lilly & Company for Cialis®

Paid Search Efficiency: Sunovion Pharmaceuticals for Latuda®

"We created the BoBs to honor operational excellence, so essential to a company's commercial success in the marketplace," said Gary McWalters, President of TGaS. "We congratulate the winners for their outstanding achievements."

The awards are based on benchmarks conducted for life sciences companies in the biopharmaceutical industry. The methodology includes the use of TGaS's patented Pharmastance® technology, which allows for capabilities and efficiency comparisons among a cohort of peer companies. The benchmark data is drawn from a variety of quantitative and qualitative sources and goes through special processes to ensure an "apples-to-apples" comparison.

About TGaS Advisors

TGaS Advisors is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. Within large, mid-size, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes 50 experienced professionals, most with senior level experience in the life sciences and related industries.